Get a Quote

Home » Billing & Coding Guides » CPT 99213 vs 99214: How to Choose the Right E/M Level

CPT 99213 vs 99214: How to Choose the Right E/M Level

•
CPT 99213 vs 99214: How to Choose the Level

Table of Contents

  • CPT code 99213 vs 99214 comes down to complexity: 99213 is low MDM or 20 to 29 minutes, while 99214 is moderate MDM or 30 to 39 minutes. 
  • The clearest tie-breaker is prescription drug management, which counts as moderate risk on its own and moves a visit from 99213 up to 99214. 
  • Under the 2026 CMS fee schedule, the work RVU rises from 1.30 for 99213 to 1.92 for 99214, about 48 percent more physician work value. 
  • Undercoding a qualifying 99214 as 99213 forfeits roughly $40 per visit, which adds up to about $9,600 a year at just 20 visits a month. 
  • The visit level follows documented MDM or time, not the appointment length, so the note must show the problems addressed, data reviewed, and risk. 

99213 and 99214 are the two most billed office visit codes in US medicine, and the line between them decides a lot of money. Under the 2026 Medicare Physician Fee Schedule, the work RVU rises from 1.30 for 99213 to 1.92 for 99214, about 48 percent more physician work value, and the payment gap runs roughly $40 per visit. Multiply that across a full schedule and the choice between these two codes is one of the highest-stakes decisions a practice makes every day. Get it right consistently, and you capture what you earned without inviting an audit. This guide breaks down the difference and, more importantly, how to decide. 

Current as of 2026. Always verify code status and payment with your specific payer, since policies change.

Criteria comparison: 99213 vs 99214

Criteria 

CPT 99213 (low complexity) 

CPT 99214 (moderate complexity) 

Patient type 

Established only 

Established only 

Total time 

20 to 29 minutes on the date of service 

30 to 39 minutes on the date of service 

History and exam 

Medically appropriate; does not determine the level since 2021 

Medically appropriate; does not determine the level since 2021 

Medical decision making 

Low (two of three elements at low) 

Moderate (two of three elements at moderate) 

Problems addressed 

One stable chronic illness, or two or more minor problems 

Two or more stable chronic illnesses, one worsening chronic illness, or a new problem with a workup 

Data reviewed 

Limited (a test or external note) 

Moderate (ordering and reviewing tests, external records, or discussion with another provider) 

Risk 

Low, such as over-the-counter management 

Moderate, such as prescription drug management 

Typical scenarios 

Routine follow-up, stable chronic condition, minor acute problem, simple refill 

Multiple chronic conditions managed, a worsening condition, a new significant problem, active medication management 

2026 work RVU 

1.30 

1.92 (about 48 percent higher) 

Relative Medicare payment 

Baseline 

Roughly $40 more per visit (non-facility, 2026) 

Audit risk 

Lower 

Higher; moderate-level notes draw more scrutiny and payer downcoding 

Documentation focus 

Problem status, limited data, low risk 

Two documented moderate elements, especially the risk driver, stated explicitly 

Payment figures vary by locality and update annually, so confirm the specific dollar amount with the CMS PFS Look-Up Tool. The RVU values are the fixed national figures from the 2026 CMS fee schedule. 

Medical Billing

Neolytix manages the full billing lifecycle across specialties, from clean claim submission to denial resolution, with reporting that gives you full visibility into performance.

The core difference: low versus moderate complexity

Since the 2021 E/M overhaul, both codes are chosen by medical decision making or total time, not by history and exam. The whole distinction is the level of complexity. 

Medical decision making is scored across three elements: the number and complexity of problems addressed, the amount and complexity of data reviewed, and the risk of the management decisions. You reach a level by meeting two of the three. 99213 needs two elements at the low level; 99214 needs two at the moderate level. 

The single clearest tie-breaker is risk, and specifically prescription drug management. Starting, adjusting, or actively monitoring a prescription medication counts as moderate risk on its own. That satisfies one moderate element immediately, so you usually need only one more, typically the problems addressed, to land at 99214. This one fact resolves a large share of 99213-versus-99214 decisions.

How to decide between them

A quick way to work through it at the point of care: 

  • Is a prescription being started, changed, or actively managed? That is moderate risk, pointing toward 99214. 
  • How many problems, and how stable? Two or more stable chronic illnesses, or one chronic illness that is worsening, or a new problem with an uncertain course, point toward 99214. A single stable problem points toward 99213. 
  • How much data? Ordering and reviewing tests, reviewing outside records, or discussing a case with another provider adds moderate weight. Little or no data points toward 99213. 
  • If MDM is a close call, check time. Thirty minutes or more of total time on the encounter date supports 99214; 20 to 29 minutes supports 99213. 

If two of the three elements genuinely reach moderate, it is 99214. If they sit at low, it is 99213. Our standalone guides to CPT code 99213 and CPT code 99214 work through each level in detail. 

Worked examples

Two established patients, same clinic, coded differently: 

Case 1, bills 99213. A 60-year-old returns for a routine check of well-controlled hypertension. Home readings are reviewed, the exam is unremarkable, and the current medication is continued unchanged. No new problem, limited data, low risk. One stable chronic illness addressed with low-risk management is low MDM. Total time was 22 minutes. This is 99213. 

Case 2, bills 99214. A 60-year-old with type 2 diabetes and hypertension returns, and the diabetes is worsening. The provider reviews a recent A1c, increases metformin, and counsels on hypoglycemia risk. Two chronic illnesses, one worsening, with prescription drug management, reaches moderate on both the problems and risk elements. That is moderate MDM, and 99214, regardless of the exact minutes. 

The difference between the two visits is not the appointment slot or the effort. It is that the second reached moderate complexity on two MDM elements, and the note shows it.

Documentation that supports each level

The code follows the documented work, not the length of the appointment slot. For either level, the note should map to the elements: 

  • The problems addressed and their status, stable, worsening, or new, in specific terms rather than a bare problem list. 
  • The data reviewed or ordered, named explicitly. 
  • The risk of the plan, with prescription drug management or other moderate-risk decisions stated plainly for a 99214. 

“Diabetes and hypertension, stable, continue meds” reads like a 99213. “Type 2 diabetes with worsening control, increased metformin, reviewed recent A1c, counseled on hypoglycemia risk” documents the moderate problems, data, and risk that support a 99214. If billing on time, state the total plainly, for example “34 minutes total on the encounter date.” 

The two-sided risk

This boundary cuts both ways, and both errors are costly. 

Undercoding is the quiet one. Defaulting to 99213 when the visit met 99214, often out of audit caution, forfeits roughly $40 on every affected visit. The math adds up fast: a practice that undercodes even 20 qualifying visits a month gives up about $800 a month, close to $9,600 a year, on this one boundary alone. Across a full panel of patients on managed medications, the loss is substantial and entirely avoidable. 

Overcoding is the visible one. Billing 99214 without documentation that supports moderate complexity invites payer scrutiny, and many Medicare Advantage and commercial plans now use automated review to flag and downcode high-level E/M visits. A note that does not clearly show two moderate elements is exposed. 

The fix for both is the same: document to the actual work, and self-audit periodically. Pull a sample of 99213 and 99214 claims and check each against its note. Our complete guide to denial management covers building that review into the workflow.

Modifiers and add-ons

Both codes take modifier 25 when billed with a significant, separately identifiable service on the same day as a minor procedure. Both can be billed for telehealth with modifier 95 when they meet the same MDM or time requirement, using place of service 10 when the patient is at home or 02 when the patient is at another site, which affects whether the visit pays at the non-facility or facility rate. And both support the Medicare visit-complexity add-on G2211 when you are the continuing focal point of the patient’s care.

The bottom line

The 99213-versus-99214 decision is not about how long the visit felt or how safe the code seems. It is about whether the documented complexity reached moderate, and prescription drug management is the fastest way to know. Bill 99214 when two MDM elements genuinely reach moderate or time hits 30 minutes, bill 99213 when they sit at low, and let the note decide rather than habit. For practices that would rather not police this boundary claim by claim, Neolytix has supported healthcare organizations across the United States for over 14 years, with E/M coding review built into its medical billing services so these high-volume claims are accurate before they go out. 

Schedule a Consultation

Neolytix partners with healthcare organizations across revenue cycle, credentialing, and administrative operations ,14+ years of expertise and AI-enabled automation to reduce inefficiencies and drive sustainable growth.

This guide reflects Neolytix’s expertise in healthcare revenue cycle management and is intended for educational purposes only. It does not constitute legal or compliance advice. CPT codes and reimbursement rates are periodically updated by the AMA and CMS.

Sources

Frequently Asked Questions

What is the difference between 99213 and 99214?

Both are established patient office visits, separated by complexity and time. 99213 requires low medical decision making or 20 to 29 minutes. 99214 requires moderate MDM or 30 to 39 minutes. The most common factor that moves a visit from 99213 to 99214 is a moderate-risk decision such as prescription drug management.

Often yes. Prescription drug management counts as moderate risk on its own, which satisfies one of the three MDM elements at the moderate level. Paired with one more moderate element, usually the problems addressed, it supports 99214 rather than 99213. Starting, adjusting, or actively monitoring a prescription medication qualifies when documented. 

Under the 2026 Medicare Physician Fee Schedule, 99214 pays roughly $40 more per visit than 99213 in the non-facility setting, and its work RVU is about 48 percent higher, 1.92 versus 1.30. The exact amount varies by locality and payer, so verify current rates with the CMS PFS Look-Up Tool. 

Ask whether the visit reaches moderate complexity. Two or more stable chronic illnesses, one worsening chronic illness, a new problem with a workup, or prescription drug management point to 99214. A single stable problem with minimal data and low risk, or 20 to 29 minutes, points to 99213. The documentation decides it.

99213 requires 20 to 29 minutes of total time on the encounter date, and 99214 requires 30 to 39 minutes. Both count the billing provider’s chart review, the visit, counseling, coordination, and documentation on that date. Staff time does not count, and the 30-minute mark is the line between the two.

Share:

Table of Contents

Credentialing Delays Are Costing You $45K–$150K Per Provider

  • Cut Credentialing Cycle Times From 120 Days to Under 45
  • Free Downloadable Guide

Neolytix Identifies an Average of $341K in Payer Contract Revenue Opportunities — Get Your Assessment Done Today